JAMA最新文献

筛选
英文 中文
Incentivizing Network Adequacy in Medicare Advantage 激励医疗保险优势网络的充分性
JAMA Pub Date : 2024-11-11 DOI: 10.1001/jama.2024.18561
John A. Graves, Gabrielle Lyons
{"title":"Incentivizing Network Adequacy in Medicare Advantage","authors":"John A. Graves, Gabrielle Lyons","doi":"10.1001/jama.2024.18561","DOIUrl":"https://doi.org/10.1001/jama.2024.18561","url":null,"abstract":"This Viewpoint discusses enrollment in Medicare Advantage vs traditional Medicare among older adults and common reasons for plan disenrollment, including the lack of in-network physicians and hospitals.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142598513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcific Aortic Stenosis 钙化性主动脉瓣狭窄
JAMA Pub Date : 2024-11-11 DOI: 10.1001/jama.2024.16477
Catherine M. Otto, David E. Newby, Graham S. Hillis
{"title":"Calcific Aortic Stenosis","authors":"Catherine M. Otto, David E. Newby, Graham S. Hillis","doi":"10.1001/jama.2024.16477","DOIUrl":"https://doi.org/10.1001/jama.2024.16477","url":null,"abstract":"ImportanceCalcific aortic stenosis (AS) restricts the aortic valve opening during systole due to calcification and fibrosis of either a congenital bicuspid or a normal trileaflet aortic valve. In the US, AS affects 1% to 2% of adults older than 65 years and approximately 12% of adults older than 75 years. Worldwide, AS leads to more than 100 000 deaths annually.ObservationsCalcific AS is characterized by aortic valve leaflet lipid infiltration and inflammation with subsequent fibrosis and calcification. Symptoms due to severe AS, such as exercise intolerance, exertional dyspnea, and syncope, are associated with a 1-year mortality rate of up to 50% without aortic valve replacement. Echocardiography can detect AS and measure the severity of aortic valve dysfunction. Although progression rates vary, once aortic velocity is higher than 2 m/s, progression to severe AS occurs typically within 10 years. Severe AS is defined by an aortic velocity 4 m/s or higher, a mean gradient 40 mm Hg or higher, or a valve area less than or equal to 1.0 cm<jats:sup>2</jats:sup>. Management of mild to moderate AS and asymptomatic severe AS consists of patient education about the typical progression of disease; clinical and echocardiographic surveillance at intervals of 3 to 5 years for mild AS, 1 to 2 years for moderate AS, and 6 to 12 months for severe AS; and treatment of hypertension, hyperlipidemia, and cigarette smoking as indicated. When a patient with severe AS develops symptoms, surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) is recommended, which restores an average life expectancy; in patients aged older than 70 years with a low surgical risk, 10-year all-cause mortality was 62.7% with TAVI and 64.0% with SAVR. TAVI is associated with decreased length of hospitalization, more rapid return to normal activities, and less pain compared with SAVR. However, evidence supporting TAVI for patients aged younger than 65 years and long-term outcomes of TAVI are less well defined than for SAVR. For patients with symptomatic severe AS, the 2020 American College of Cardiology/American Heart Association guideline recommends SAVR for individuals aged 65 years and younger, SAVR or TAVI for those aged 66 to 79 years, and TAVI for individuals aged 80 years and older or those with an estimated surgical mortality of 8% or higher.ConclusionsCalcific AS is a common chronic progressive condition among older adults and is diagnosed via echocardiography. Symptomatic patients with severe AS have a mortality rate of up to 50% after 1 year, but treatment with SAVR or TAVI reduces mortality to that of age-matched control patients. The type and timing of valve replacement should be built on evidence-based guidelines, shared decision-making, and involvement of a multidisciplinary heart valve team.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142598515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver 联合国会议强调抗菌药耐药性的 "顿悟"--缺乏抗生素供应是关键驱动因素
JAMA Pub Date : 2024-11-08 DOI: 10.1001/jama.2024.21046
Kate Schweitzer
{"title":"UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver","authors":"Kate Schweitzer","doi":"10.1001/jama.2024.21046","DOIUrl":"https://doi.org/10.1001/jama.2024.21046","url":null,"abstract":"This Medical News article discusses the first high-level meeting on antimicrobial resistance at the United Nations since 2016 and a new report on the global burden of bacterial antimicrobial resistance.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Academies President on How to Use Generative AI Responsibly in Scientific Research 美国国家科学院院长谈如何在科学研究中负责任地使用生成式人工智能
JAMA Pub Date : 2024-11-08 DOI: 10.1001/jama.2024.14025
Kirsten Bibbins-Domingo, Yulin Hswen
{"title":"National Academies President on How to Use Generative AI Responsibly in Scientific Research","authors":"Kirsten Bibbins-Domingo, Yulin Hswen","doi":"10.1001/jama.2024.14025","DOIUrl":"https://doi.org/10.1001/jama.2024.14025","url":null,"abstract":"This Medical News article is an interview with National Academy of Sciences President Marcia McNutt, PhD, and <jats:italic>JAMA</jats:italic> Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, about responsible use of generative AI for scientific research.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes 在新疗法类别中,相互竞争的制造商向医生支付的行业费用
JAMA Pub Date : 2024-11-07 DOI: 10.1001/jama.2024.20842
Q. Wilton Sun, Joseph S. Ross
{"title":"Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes","authors":"Q. Wilton Sun, Joseph S. Ross","doi":"10.1001/jama.2024.20842","DOIUrl":"https://doi.org/10.1001/jama.2024.20842","url":null,"abstract":"This study analyzes the extent and persistence of payments to physicians from competing manufacturers after receipt of payment from manufacturers of first-in-class products entering 6 novel therapeutic classes.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteophyte 骨质增生
JAMA Pub Date : 2024-11-07 DOI: 10.1001/jama.2024.22028
Lucy Zhao
{"title":"Osteophyte","authors":"Lucy Zhao","doi":"10.1001/jama.2024.22028","DOIUrl":"https://doi.org/10.1001/jama.2024.22028","url":null,"abstract":"In this narrative medicine essay, a medical student discusses the challenges of conveying her grandmother’s feelings to her physician while serving as an interpreter for her grandparents’ clinic visits.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Working With Medical Interpreters 与医疗口译员合作
JAMA Pub Date : 2024-11-07 DOI: 10.1001/jama.2024.20900
Zara Latif, Jane Kontrimas, Haider J. Warraich
{"title":"Working With Medical Interpreters","authors":"Zara Latif, Jane Kontrimas, Haider J. Warraich","doi":"10.1001/jama.2024.20900","DOIUrl":"https://doi.org/10.1001/jama.2024.20900","url":null,"abstract":"This JAMA Insights discusses the important role that interpreters play in facilitating communication between patients with limited English-language proficiency and their health care team and provides steps that can be taken to improve communication with remote interpreters for patients.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
With Nearsightedness in Children on the Rise, Experts Push for Outdoor Time, Disease Designation 儿童近视呈上升趋势,专家呼吁增加户外活动时间并指定疾病名称
JAMA Pub Date : 2024-10-25 DOI: 10.1001/jama.2024.21043
Kate Schweitzer
{"title":"With Nearsightedness in Children on the Rise, Experts Push for Outdoor Time, Disease Designation","authors":"Kate Schweitzer","doi":"10.1001/jama.2024.21043","DOIUrl":"https://doi.org/10.1001/jama.2024.21043","url":null,"abstract":"This Medical News article discusses new research on global trends in nearsightedness, possible ways to prevent and treat it, and calls to classify it as a disease.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study: MMR Vaccine Protection Wanes Slightly Over Time. 研究:麻腮风疫苗的保护作用随时间略有减弱。
JAMA Pub Date : 2024-10-25 DOI: 10.1001/jama.2024.21822
Samantha Anderer
{"title":"Study: MMR Vaccine Protection Wanes Slightly Over Time.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.21822","DOIUrl":"https://doi.org/10.1001/jama.2024.21822","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Few Patients Receive Testing After Abnormal Urine Protein Results. 尿蛋白结果异常后接受检测的患者寥寥无几。
JAMA Pub Date : 2024-10-25 DOI: 10.1001/jama.2024.21826
Samantha Anderer
{"title":"Few Patients Receive Testing After Abnormal Urine Protein Results.","authors":"Samantha Anderer","doi":"10.1001/jama.2024.21826","DOIUrl":"https://doi.org/10.1001/jama.2024.21826","url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信